Topic Archives: First Eagle Gold (SGGDX)

December 1, 2016 / Travis Johnson, Stock Gumshoe

What’s Chris Mayer’s “Bonner Family Gold Portfolio” Pick?

I always like paying attention to Chris Mayer’s recommendations — not because they’re infallible, but because he has a solid and logical process for choosing stocks, and I’ve found his arguments pretty compelling the few times I’ve heard him speak (and, of course, some of those stocks he has profiled have done well — though […]

Comments

Travis Johnson, Stock Gumshoe on “‘Cut & Paste’ Disease From Your Body” — what’s this “Living Software” Business from Dylan Jovine? / Nov 14, 1:01am

We keep seeing this ad and getting more questions about it -- the ad hasn't changed in any big way that I've noticed, th...

Nicholas E Brown on Blanco’s “No More Diseases… The Moment The World Stands Still” Stock / Jun 1, 2:50pm

I've often wondered how companies that develop something that eliminates disease, such as this, will make money. The OUT...

Tom M on What are those “Mysterious M-Boxes” teased by Nova-X Report? / Apr 4, 4:10pm

$12 trillion? That's over half of the US economy. Even over 10 years, it's never going to happen. I guess for $79/yea...

Tom M on “Potential FDA Approval could change your life” pitch from Matt McCall / Jan 23, 2:57pm

Well I just hope this is a boomer like the "God Key" stocks (EDIT, CRSP) which are about 50% lower from their peaks in 2...

mag on “‘Cut & Paste’ Disease From Your Body” — what’s this “Living Software” Business from Dylan Jovine? / Dec 31, 3:00pm

Although the last three months is a short time period, it's the only one I could research easily. Over that period, the...

gdoggcrunch on written by reader

What are the 3 “Data Cartel” Companies pitched by Tony Deltario’s Growth Stock Advisor? / Nov 6, 7:18pm

I think its cell data. https://www.investors.com/news/technology/crispr-gene-editing-biotech-companies/ https://mo...

narr01 on “‘Cut & Paste’ Disease From Your Body” — what’s this “Living Software” Business from Dylan Jovine? / Nov 5, 9:06pm

There've been a lot of uncertainties around the CRISPR companies, but I think right now the elephant in the room is the ...

gdoggcrunch on written by reader

IBD’sLiving Software Sells for $83,000 on a biotech wilt Bill Gates as an investor / Oct 27, 3:34pm

Found the article I remember that talks about the patent license. https://www.forbes.com/sites/matthewherper/2015/08/10/...

Tom M on Kent Moors says “20% of the world’s supply of one of the most critical natural resources will disappear” / Oct 15, 2:52pm

Amazing how they can predict uranium demand (prices) over the next 15 years or more. After you've spent about $75,000-$...

Ron Homan on Cancer: The Lay of the Land in 2018 / Oct 8, 5:30pm

Thanks for putting everything into perspective. I read about "exciting new developments" every day, and it is impossibl...

realtor24 on Examining McCall’s “The First Trillion Dollar Patent Will Release the Largest Royalty Payments Ever Known to Mankind” pitch / Oct 1, 3:01pm

I bought CRSP and I am up over 60%. Might think about the other two as well. This technology will take some time to deve...

ddeary on Examining McCall’s “The First Trillion Dollar Patent Will Release the Largest Royalty Payments Ever Known to Mankind” pitch / Oct 1, 2:47pm

I gave up on EDIT, NTLA, and CRSP and went with Illumina, Inc. (ILMN) which is similar but much less volatile. And ILMN ...

Clemdane on written by reader

This “Golden Pistol”, set to blast 1 final killshot at Big Pharma… / Sep 26, 6:31pm

If you read all the way down to the end of Altucher's epic screed you see that he says you should buy all three: EDIT, N...

Travis Johnson, Stock Gumshoe on Ask a Stupid Question… / May 21, 10:36am

I have a really hard time with R&D companies or very early-stage clinical biotechs -- partly because it's an end market ...